Adoptive T-cell therapy after allogeneic hematopoietic stem cell transplantation (HCT) holds promise for amplifying the graft-versus-leukemia/tumor effect without graft-versus-host disease (GVHD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback